Adarza BioSystems Completes a $5 M Series-B closing
March 22, 2016
Rochester, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and [...]
March 22, 2016
Dr Luning Liu with his JPK NanoWizard® system at the University of LiverpoolJPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the use of their NanoWizard® ULTRA Speed AFM system at the University of Liverpool in the group of Dr Luning Liu of the Institute of [...]
Horizon Discovery Group plc Launches HDx™ RNA Fusion Reference Standards
March 22, 2016
Cambridge, UK, - Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Company”), the leading international gene editing company supplying tools and services that power genomics research and the development of personalized medicines announces the launch of HDx FFPE RNA Fusion Reference Standards, independent analytical controls for the optimization and validation of targeted RNA-seq, endpoint [...]
March 22, 2016
908 Devices, a pioneer of purpose-built analytical devices for chemical analysis, announced the introduction of G908, a universal petrochemical analyzer that combines the company’s patented and award-winning high-pressure mass spectrometry (HPMS) technology with the separating power of ballistic gas chromatography (GC). The combination of HPMS and GC provides exceptionally fast compositional analysis, improving efficiency and [...]
Diagenode Introduces Epigenetics Services
March 21, 2016
Denville, NJ -- Diagenode, a leading global provider of complete solutions for epigenetics research, announced the launch of its new epigenetics services offering. The services include both ChIP-sequencing and reduced representation bisulfite sequencing (RRBS). “The new services offering is perfect for both newcomers to epigenetics as well as high-throughput labs that want to utilize Diagenode’s [...]
March 21, 2016
SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Noridian Healthcare Solutions, LLC, a Medicare Administrative Contractor (MAC) for two Medicare jurisdictions covering 13 states, has issued favorable final local coverage determinations (LCDs) for the Prosigna® Breast Cancer Assay, effective for services [...]
Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
March 21, 2016
MINNEAPOLIS, - Bio-Techne Corporation (NASDAQ: TECH) announced that it has completed the acquisition of Zephyrus Biosciences. Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne. Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single cell analysis market, Zephyrus’s first product, the Z1™ System, [...]
Jenoptik mourns the passing of Lothar Späth
March 21, 2016
We are deeply saddened by the passing of Lothar Späth, former Chairman of the Jenoptik Executive and Supervisory Boards, at the age of 78 in Stuttgart. “Lothar Späth was both an important politician and entrepreneur. We have now lost a person who created and changed a great deal with his vision, courage, and ability – [...]
Novasep and GTP Technology join forces to ease production of mAbs and recombinant proteins
March 21, 2016
Lyon and Toulouse, France, – Novasep, a leading supplier of services and technologies for the life sciences industry, and GTP (Gene-to-Proteins) Technology, a CDMO providing recombinant protein and process development services, today announce a partnership that combines their expertise in monoclonal antibodies (mAbs) production. The partners aim to facilitate the development of therapeutic and diagnostic [...]
Gen9 Announces Next Generation of the BioFab® DNA Synthesis Platform
March 21, 2016
CAMBRIDGE, MA – Gen9 unveiled the next generation of the BioFab® DNA synthesis platform enabling the manufacture of mass quantities of high quality, long-length clonal DNA constructs at prices as low as 3 cents per base pair. The new offering, available now as a standard product, is tailored for scientists who utilize megabase quantities of [...]
